As Pfizer and BioNTech announced this week that results of their COVID-19 vaccine have exceeded expectations, the technology behind the vaccine (messenger RNA, or mRNA) has taken center stage. Last month, Moderna Therapeutics, one of the global leaders in the race to produce a COVID-19 vaccine using Read More>>
Categories Business, Guest Contributors, IP News, Licensing, Patents, Technology & Innovation, COVID-19, Guest Contributor, innovation, intellectual property, Moderna, mRNA, patent, Patent pledge, patents, Pfizer, vaccine
